Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HNS 32

Known as: HNS-32 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Active faceted Cu2O hollow nanospheres for unprecedented adsorption and visible-light degradation of pollutants.
We report the well-designed active {1 1 0} and {1 1 1} faceted Cu2O hollow nanospheres (Cu2O-HNs) for the quick removal of the… Expand
2018
2018
Open Access: Is There a Predator at the Door?
Neurogenic inflammation plays a role in the pathophysiology of allergic rhinitis. Highly effective in reducing the sensory… Expand
2017
2017
Evolution of gender representation among Canadian OTL-HNS residents: a 27-year analysis
BackgroundThe proportion of females enrolling into medical schools has been growing steadily. However, the representation of… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
2017
2017
Plasmon enhanced light absorption in aluminium@Hematite core shell hybrid nanocylinders: the critical role of length
The light absorption as well as the near field enhancements properties of Al@α-Fe2O3 core shell hybrid nanocylinders (HNs) have… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2017
2017
매뉴얼 모델링 및 시나리오 시뮬레이션을 통한 해상 HNS 유출사고 초동대응체계 개선 방안 평가
국내외 해상 HNS 물동량이 증가하고 국내 해역에서 HNS 유출사고가 수차례 발생함에 따라, HNS 사고 대응 체계 강화에 대한 요구가 증가하고 있다. 특히 HNS… Expand
2004
2004
Effects of HNS-32, a novel antiarrhythmic drug, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats
HNS-32 (N1,N1-dimethyl-N2-(2-pyridylmethyl)-5-isopropyl-3, 8-dimethylazulene-1-carboxamidine: CAS 186086-10-2) is a newly… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2002
2002
Cardiovascular effects of orally administered HNS-32, an originally synthesized azulene-1-carboxamidine derivative, assessed in the in vivo rat model.
HNS-32, an azulene-1-carboxamidine derivative, is an originally synthesized antiarrhythmic compound. Its cardiovascular effects… Expand
  • figure 1
  • figure 2
  • figure 3
2001
2001
Effects of HNS-32, a Novel Antiarrhythmic Agent, on Guinea-Pig Myocardium
The electrophysiological and mechanical effects of HNS-32, a novel azulene-1-carboxamidine derivative with antiarrhythmic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2000
2000
HNS-32, a novel azulene-1-carboxamidine derivative, inhibits nifedipine-sensitive and -insensitive contraction of the isolated rabbit aorta
Abstract. The vasorelaxant profile of a novel azulene-1-carboxamidine derivative, HNS-32 [N1,N1-dimethyl-N2-(2-pyridylmethyl)-5… Expand
  • table 1
  • figure 4
  • figure 6
  • figure 7
  • figure 8
2000
2000
Cerebral artery selective inhibition of protein kinase c-mediated contraction by hns-32, a novel azulene-1-carboxamidine derivative.
The vasorelaxant actions of a novel azulene-1-carboxamidine derivative, HNS-32, were investigated on the tension development… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE